Cardiology Genetic Testing

Get to the heart of your patient’s condition with comprehensive cardiac genetic testing.

Monogenic cardiovascular disorders can lead to severe premature cardiovascular disease and early death.¹ Up to 45% of congenital heart diseases² and up to 50% of hypertrophic cardiomyopathies³ have monogenic etiologies.

Genetic testing is a trusted diagnostic tool

The American Heart Association compiled research and guidelines for using genetic testing to help you diagnose and manage patient care with these and other cardiovascular conditions.

Sponsored testing for cardiac conditions

Discover sponsored testing for a variety of cardiovascular disorders.

circle graph with title "Positive cases by variant type and detection method" Graph shows 63% SNV, 35% CNV - NGS and CMA, and 2% CNV - NGS only

Discover the PGmax™ panel that detected more CNVs than parallel CMA testing

An internal study found that the CNV analysis included with the PGmax – Comprehensive Congenital Heart Disease (CHD) Panel had a higher positivity rate than a Chromosomal Microarray (CMA) test that was run in parallel for each sample.* Why does this matter? Molecularly explainable CHDs can be due to both large copy number variants and sequence variants. By starting with NGS that includes CNV analysis, you can get the whole answer without multiple tests.⁴

Reach out to an expert

Our team of experts can help you explore testing options, place an order, ship a sample, and understand results.